XML 90 R83.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Financial instruments - Fair value hierarchy (Details) - At fair value - BRL (R$) R$ in Thousands | Jun. 30, 2024 | Dec. 31, 2023
--- | --- | ---
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | R$ 38,532,746 | R$ 35,999,928
Financial liabilities | 5,732,329 | 2,436,072
At fair value through profit or loss |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial liabilities | 5,732,329 | 2,436,072
At fair value through profit or loss | Derivative financial instruments |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial liabilities | 5,732,329 | 2,436,072
Level 2 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 18,699,634 | 17,697,740
Financial liabilities | 5,732,329 | 2,436,072
Level 2 | At fair value through profit or loss |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial liabilities | 5,732,329 | 2,436,072
Level 2 | At fair value through profit or loss | Derivative financial instruments |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial liabilities | 5,732,329 | 2,436,072
Level 3 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 19,833,112 | 18,302,188
At fair value through profit or loss |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 18,699,634 | 17,697,740
At fair value through profit or loss | Level 2 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 18,699,634 | 17,697,740
At fair value through profit or loss | Derivative financial instruments |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 3,884,621 | 4,430,454
At fair value through profit or loss | Derivative financial instruments | Level 2 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 3,884,621 | 4,430,454
At fair value through profit or loss | Marketable securities |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 14,815,013 | 13,267,286
At fair value through profit or loss | Marketable securities | Level 2 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 14,815,013 | 13,267,286
At fair value through other comprehensive income |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 31,364 | 23,606
At fair value through other comprehensive income | Level 3 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 31,364 | 23,606
At fair value through other comprehensive income | Other investments |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 31,364 | 23,606
At fair value through other comprehensive income | Other investments | Level 3 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 31,364 | 23,606
Financial assets at amortised cost, category [member] |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 19,801,748 | 18,278,582
Financial assets at amortised cost, category [member] | Level 3 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 19,801,748 | 18,278,582
Financial assets at amortised cost, category [member] | Biological assets [member] |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | 19,801,748 | 18,278,582
Financial assets at amortised cost, category [member] | Biological assets [member] | Level 3 |  |
Disclosure of detailed information about financial instruments [line items] |  |
Financial assets | R$ 19,801,748 | R$ 18,278,582

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 35M -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard -URIDate 2023-03-23 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 35N -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard -URIDate 2023-03-23 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 35I -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_FinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity’s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity’s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_FinancialLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfLiabilitiesAxis=ifrs-full_DerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=ifrs-full_DerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=suz_IfrsOtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=ifrs-full_BiologicalAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |